nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—SCN10A—melanoma	0.522	1	CbGaD
Ropivacaine—CYP1A2—Carmustine—melanoma	0.0571	0.229	CbGbCtD
Ropivacaine—CYP1A2—Vemurafenib—melanoma	0.0452	0.181	CbGbCtD
Ropivacaine—CYP3A4—Temozolomide—melanoma	0.0432	0.173	CbGbCtD
Ropivacaine—CYP2D6—Vemurafenib—melanoma	0.0372	0.149	CbGbCtD
Ropivacaine—CYP1A2—Dacarbazine—melanoma	0.0346	0.139	CbGbCtD
Ropivacaine—CYP3A4—Vemurafenib—melanoma	0.0237	0.095	CbGbCtD
Ropivacaine—CYP3A4—Docetaxel—melanoma	0.00812	0.0326	CbGbCtD
Ropivacaine—Tocainide—SCN11A—melanoma	0.00185	0.274	CrCbGaD
Ropivacaine—Levobupivacaine—SCN10A—melanoma	0.00115	0.17	CrCbGaD
Ropivacaine—Mepivacaine—SCN10A—melanoma	0.000937	0.139	CrCbGaD
Ropivacaine—Bupivacaine—SCN10A—melanoma	0.000919	0.136	CrCbGaD
Ropivacaine—Tocainide—SCN10A—melanoma	0.000697	0.103	CrCbGaD
Ropivacaine—Lidocaine—SCN10A—melanoma	0.000538	0.0796	CrCbGaD
Ropivacaine—Mood swings—Temozolomide—melanoma	0.00041	0.00408	CcSEcCtD
Ropivacaine—Hypokalaemia—Carmustine—melanoma	0.000408	0.00405	CcSEcCtD
Ropivacaine—Skin disorder—Vemurafenib—melanoma	0.000405	0.00402	CcSEcCtD
Ropivacaine—Respiratory failure—Docetaxel—melanoma	0.000404	0.00402	CcSEcCtD
Ropivacaine—Pulmonary embolism—Docetaxel—melanoma	0.000397	0.00394	CcSEcCtD
Ropivacaine—Phosphatase alkaline increased—Docetaxel—melanoma	0.000397	0.00394	CcSEcCtD
Ropivacaine—Injection site reaction—Docetaxel—melanoma	0.000395	0.00392	CcSEcCtD
Ropivacaine—Hypokalaemia—Temozolomide—melanoma	0.000394	0.00392	CcSEcCtD
Ropivacaine—Breast disorder—Temozolomide—melanoma	0.000392	0.00389	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Bleomycin—melanoma	0.00039	0.00388	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00039	0.00388	CcSEcCtD
Ropivacaine—Hypotension—Vemurafenib—melanoma	0.000389	0.00387	CcSEcCtD
Ropivacaine—Lidocaine—EGFR—melanoma	0.000389	0.0575	CrCbGaD
Ropivacaine—Myocardial infarction—Bleomycin—melanoma	0.000388	0.00385	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Temozolomide—melanoma	0.000382	0.0038	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00038	0.00377	CcSEcCtD
Ropivacaine—Haematuria—Bleomycin—melanoma	0.000377	0.00375	CcSEcCtD
Ropivacaine—Abdominal distension—Temozolomide—melanoma	0.000377	0.00375	CcSEcCtD
Ropivacaine—Neuropathy—Docetaxel—melanoma	0.000373	0.0037	CcSEcCtD
Ropivacaine—Sweating increased—Temozolomide—melanoma	0.000365	0.00362	CcSEcCtD
Ropivacaine—Constipation—Vemurafenib—melanoma	0.000356	0.00354	CcSEcCtD
Ropivacaine—Hypoaesthesia—Bleomycin—melanoma	0.000354	0.00351	CcSEcCtD
Ropivacaine—Dysuria—Temozolomide—melanoma	0.00035	0.00348	CcSEcCtD
Ropivacaine—Hyperglycaemia—Carmustine—melanoma	0.00035	0.00347	CcSEcCtD
Ropivacaine—Depression—Carmustine—melanoma	0.000345	0.00342	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Carmustine—melanoma	0.000339	0.00336	CcSEcCtD
Ropivacaine—Hyperglycaemia—Temozolomide—melanoma	0.000338	0.00336	CcSEcCtD
Ropivacaine—Urinary tract infection—Carmustine—melanoma	0.000336	0.00334	CcSEcCtD
Ropivacaine—Phlebitis—Docetaxel—melanoma	0.000334	0.00332	CcSEcCtD
Ropivacaine—Depression—Temozolomide—melanoma	0.000333	0.00331	CcSEcCtD
Ropivacaine—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000331	0.00329	CcSEcCtD
Ropivacaine—Body temperature increased—Vemurafenib—melanoma	0.000329	0.00327	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Temozolomide—melanoma	0.000327	0.00325	CcSEcCtD
Ropivacaine—Urinary tract infection—Temozolomide—melanoma	0.000325	0.00322	CcSEcCtD
Ropivacaine—Chills—Bleomycin—melanoma	0.000319	0.00317	CcSEcCtD
Ropivacaine—Erythema—Bleomycin—melanoma	0.000309	0.00307	CcSEcCtD
Ropivacaine—Hallucination—Carmustine—melanoma	0.000309	0.00307	CcSEcCtD
Ropivacaine—Hypoaesthesia—Carmustine—melanoma	0.000309	0.00307	CcSEcCtD
Ropivacaine—Hypersensitivity—Vemurafenib—melanoma	0.000307	0.00305	CcSEcCtD
Ropivacaine—Oedema peripheral—Carmustine—melanoma	0.000306	0.00304	CcSEcCtD
Ropivacaine—Atrial fibrillation—Docetaxel—melanoma	0.000304	0.00302	CcSEcCtD
Ropivacaine—Asthenia—Vemurafenib—melanoma	0.000299	0.00297	CcSEcCtD
Ropivacaine—Hypoaesthesia—Temozolomide—melanoma	0.000298	0.00296	CcSEcCtD
Ropivacaine—Hallucination—Temozolomide—melanoma	0.000298	0.00296	CcSEcCtD
Ropivacaine—Chills—Dactinomycin—melanoma	0.000297	0.00295	CcSEcCtD
Ropivacaine—Urinary tract disorder—Temozolomide—melanoma	0.000296	0.00294	CcSEcCtD
Ropivacaine—Oedema peripheral—Temozolomide—melanoma	0.000295	0.00293	CcSEcCtD
Ropivacaine—Pruritus—Vemurafenib—melanoma	0.000295	0.00293	CcSEcCtD
Ropivacaine—Urethral disorder—Temozolomide—melanoma	0.000294	0.00292	CcSEcCtD
Ropivacaine—Erythema—Dactinomycin—melanoma	0.000288	0.00287	CcSEcCtD
Ropivacaine—Ill-defined disorder—Bleomycin—melanoma	0.000287	0.00285	CcSEcCtD
Ropivacaine—Anaemia—Bleomycin—melanoma	0.000286	0.00284	CcSEcCtD
Ropivacaine—Diarrhoea—Vemurafenib—melanoma	0.000285	0.00283	CcSEcCtD
Ropivacaine—Tinnitus—Temozolomide—melanoma	0.000279	0.00278	CcSEcCtD
Ropivacaine—Malaise—Bleomycin—melanoma	0.000279	0.00277	CcSEcCtD
Ropivacaine—Cardiac disorder—Temozolomide—melanoma	0.000278	0.00276	CcSEcCtD
Ropivacaine—Arrhythmia—Carmustine—melanoma	0.000277	0.00275	CcSEcCtD
Ropivacaine—Dizziness—Vemurafenib—melanoma	0.000276	0.00274	CcSEcCtD
Ropivacaine—Mental disorder—Carmustine—melanoma	0.000272	0.0027	CcSEcCtD
Ropivacaine—Erythema—Carmustine—melanoma	0.00027	0.00268	CcSEcCtD
Ropivacaine—Cough—Bleomycin—melanoma	0.00027	0.00268	CcSEcCtD
Ropivacaine—Chills—Temozolomide—melanoma	0.000269	0.00267	CcSEcCtD
Ropivacaine—Ill-defined disorder—Dactinomycin—melanoma	0.000268	0.00266	CcSEcCtD
Ropivacaine—Anaemia—Dactinomycin—melanoma	0.000267	0.00265	CcSEcCtD
Ropivacaine—Vomiting—Vemurafenib—melanoma	0.000265	0.00263	CcSEcCtD
Ropivacaine—Chest pain—Bleomycin—melanoma	0.000263	0.00262	CcSEcCtD
Ropivacaine—Myalgia—Bleomycin—melanoma	0.000263	0.00262	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Docetaxel—melanoma	0.000263	0.00261	CcSEcCtD
Ropivacaine—Rash—Vemurafenib—melanoma	0.000263	0.00261	CcSEcCtD
Ropivacaine—Mental disorder—Temozolomide—melanoma	0.000263	0.00261	CcSEcCtD
Ropivacaine—Dermatitis—Vemurafenib—melanoma	0.000262	0.00261	CcSEcCtD
Ropivacaine—Back pain—Carmustine—melanoma	0.000261	0.00259	CcSEcCtD
Ropivacaine—Headache—Vemurafenib—melanoma	0.000261	0.00259	CcSEcCtD
Ropivacaine—Erythema—Temozolomide—melanoma	0.000261	0.00259	CcSEcCtD
Ropivacaine—Breast disorder—Docetaxel—melanoma	0.00026	0.00259	CcSEcCtD
Ropivacaine—Discomfort—Bleomycin—melanoma	0.00026	0.00259	CcSEcCtD
Ropivacaine—Malaise—Dactinomycin—melanoma	0.00026	0.00258	CcSEcCtD
Ropivacaine—Cramp muscle—Docetaxel—melanoma	0.000259	0.00258	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000259	0.00258	CcSEcCtD
Ropivacaine—Confusional state—Bleomycin—melanoma	0.000255	0.00253	CcSEcCtD
Ropivacaine—Vision blurred—Carmustine—melanoma	0.000254	0.00253	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Docetaxel—melanoma	0.000254	0.00252	CcSEcCtD
Ropivacaine—Tremor—Carmustine—melanoma	0.000253	0.00251	CcSEcCtD
Ropivacaine—Anaphylactic shock—Bleomycin—melanoma	0.000252	0.00251	CcSEcCtD
Ropivacaine—Back pain—Temozolomide—melanoma	0.000252	0.00251	CcSEcCtD
Ropivacaine—Infection—Bleomycin—melanoma	0.000251	0.00249	CcSEcCtD
Ropivacaine—Anaemia—Carmustine—melanoma	0.00025	0.00248	CcSEcCtD
Ropivacaine—Agitation—Carmustine—melanoma	0.000248	0.00247	CcSEcCtD
Ropivacaine—Nausea—Vemurafenib—melanoma	0.000248	0.00246	CcSEcCtD
Ropivacaine—Thrombocytopenia—Bleomycin—melanoma	0.000247	0.00246	CcSEcCtD
Ropivacaine—Vision blurred—Temozolomide—melanoma	0.000246	0.00244	CcSEcCtD
Ropivacaine—Myalgia—Dactinomycin—melanoma	0.000246	0.00244	CcSEcCtD
Ropivacaine—Bronchospasm—Docetaxel—melanoma	0.000245	0.00243	CcSEcCtD
Ropivacaine—Tremor—Temozolomide—melanoma	0.000244	0.00243	CcSEcCtD
Ropivacaine—Discomfort—Dactinomycin—melanoma	0.000243	0.00241	CcSEcCtD
Ropivacaine—Ill-defined disorder—Temozolomide—melanoma	0.000242	0.00241	CcSEcCtD
Ropivacaine—Anaemia—Temozolomide—melanoma	0.000241	0.0024	CcSEcCtD
Ropivacaine—Agitation—Temozolomide—melanoma	0.00024	0.00238	CcSEcCtD
Ropivacaine—Angioedema—Temozolomide—melanoma	0.000238	0.00237	CcSEcCtD
Ropivacaine—Hypotension—Bleomycin—melanoma	0.000236	0.00234	CcSEcCtD
Ropivacaine—Malaise—Temozolomide—melanoma	0.000235	0.00234	CcSEcCtD
Ropivacaine—Vertigo—Temozolomide—melanoma	0.000234	0.00233	CcSEcCtD
Ropivacaine—Convulsion—Carmustine—melanoma	0.000234	0.00232	CcSEcCtD
Ropivacaine—Infection—Dactinomycin—melanoma	0.000234	0.00232	CcSEcCtD
Ropivacaine—Hypertension—Carmustine—melanoma	0.000233	0.00232	CcSEcCtD
Ropivacaine—Thrombocytopenia—Dactinomycin—melanoma	0.000231	0.00229	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Bleomycin—melanoma	0.00023	0.00229	CcSEcCtD
Ropivacaine—Myalgia—Carmustine—melanoma	0.00023	0.00228	CcSEcCtD
Ropivacaine—Chest pain—Carmustine—melanoma	0.00023	0.00228	CcSEcCtD
Ropivacaine—Anxiety—Carmustine—melanoma	0.000229	0.00228	CcSEcCtD
Ropivacaine—Cough—Temozolomide—melanoma	0.000228	0.00226	CcSEcCtD
Ropivacaine—Paraesthesia—Bleomycin—melanoma	0.000227	0.00225	CcSEcCtD
Ropivacaine—Convulsion—Temozolomide—melanoma	0.000226	0.00225	CcSEcCtD
Ropivacaine—Hypertension—Temozolomide—melanoma	0.000225	0.00224	CcSEcCtD
Ropivacaine—Dyspnoea—Bleomycin—melanoma	0.000225	0.00224	CcSEcCtD
Ropivacaine—Confusional state—Carmustine—melanoma	0.000222	0.00221	CcSEcCtD
Ropivacaine—Arthralgia—Temozolomide—melanoma	0.000222	0.00221	CcSEcCtD
Ropivacaine—Myalgia—Temozolomide—melanoma	0.000222	0.00221	CcSEcCtD
Ropivacaine—Anxiety—Temozolomide—melanoma	0.000221	0.0022	CcSEcCtD
Ropivacaine—Discomfort—Temozolomide—melanoma	0.000219	0.00218	CcSEcCtD
Ropivacaine—Infection—Carmustine—melanoma	0.000219	0.00218	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Docetaxel—melanoma	0.000219	0.00217	CcSEcCtD
Ropivacaine—Myocardial infarction—Docetaxel—melanoma	0.000218	0.00216	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Docetaxel—melanoma	0.000218	0.00216	CcSEcCtD
Ropivacaine—Jaundice—Docetaxel—melanoma	0.000216	0.00215	CcSEcCtD
Ropivacaine—Pain—Bleomycin—melanoma	0.000216	0.00214	CcSEcCtD
Ropivacaine—Thrombocytopenia—Carmustine—melanoma	0.000216	0.00214	CcSEcCtD
Ropivacaine—Tachycardia—Carmustine—melanoma	0.000215	0.00214	CcSEcCtD
Ropivacaine—Confusional state—Temozolomide—melanoma	0.000215	0.00213	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000215	0.00213	CcSEcCtD
Ropivacaine—Anaphylactic shock—Temozolomide—melanoma	0.000213	0.00212	CcSEcCtD
Ropivacaine—Infection—Temozolomide—melanoma	0.000212	0.0021	CcSEcCtD
Ropivacaine—Thrombocytopenia—Temozolomide—melanoma	0.000209	0.00207	CcSEcCtD
Ropivacaine—Feeling abnormal—Bleomycin—melanoma	0.000208	0.00207	CcSEcCtD
Ropivacaine—Skin disorder—Temozolomide—melanoma	0.000207	0.00206	CcSEcCtD
Ropivacaine—Hypotension—Carmustine—melanoma	0.000206	0.00205	CcSEcCtD
Ropivacaine—Hyperhidrosis—Temozolomide—melanoma	0.000206	0.00205	CcSEcCtD
Ropivacaine—Pain—Dactinomycin—melanoma	0.000201	0.002	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Carmustine—melanoma	0.000201	0.00199	CcSEcCtD
Ropivacaine—Urticaria—Bleomycin—melanoma	0.000201	0.00199	CcSEcCtD
Ropivacaine—Rhinitis—Docetaxel—melanoma	0.0002	0.00199	CcSEcCtD
Ropivacaine—Body temperature increased—Bleomycin—melanoma	0.0002	0.00198	CcSEcCtD
Ropivacaine—Insomnia—Carmustine—melanoma	0.000199	0.00198	CcSEcCtD
Ropivacaine—Hypoaesthesia—Docetaxel—melanoma	0.000198	0.00197	CcSEcCtD
Ropivacaine—Paraesthesia—Carmustine—melanoma	0.000198	0.00197	CcSEcCtD
Ropivacaine—Urinary tract disorder—Docetaxel—melanoma	0.000197	0.00196	CcSEcCtD
Ropivacaine—Dyspnoea—Carmustine—melanoma	0.000196	0.00195	CcSEcCtD
Ropivacaine—Oedema peripheral—Docetaxel—melanoma	0.000196	0.00195	CcSEcCtD
Ropivacaine—Somnolence—Carmustine—melanoma	0.000196	0.00195	CcSEcCtD
Ropivacaine—Urethral disorder—Docetaxel—melanoma	0.000195	0.00194	CcSEcCtD
Ropivacaine—Feeling abnormal—Dactinomycin—melanoma	0.000194	0.00193	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000194	0.00193	CcSEcCtD
Ropivacaine—Insomnia—Temozolomide—melanoma	0.000193	0.00191	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Dactinomycin—melanoma	0.000193	0.00191	CcSEcCtD
Ropivacaine—Paraesthesia—Temozolomide—melanoma	0.000191	0.0019	CcSEcCtD
Ropivacaine—Dyspnoea—Temozolomide—melanoma	0.00019	0.00189	CcSEcCtD
Ropivacaine—Somnolence—Temozolomide—melanoma	0.000189	0.00188	CcSEcCtD
Ropivacaine—Pain—Carmustine—melanoma	0.000188	0.00187	CcSEcCtD
Ropivacaine—Constipation—Carmustine—melanoma	0.000188	0.00187	CcSEcCtD
Ropivacaine—Dyspepsia—Temozolomide—melanoma	0.000187	0.00186	CcSEcCtD
Ropivacaine—Body temperature increased—Dactinomycin—melanoma	0.000186	0.00185	CcSEcCtD
Ropivacaine—Abdominal pain—Dactinomycin—melanoma	0.000186	0.00185	CcSEcCtD
Ropivacaine—Hypersensitivity—Bleomycin—melanoma	0.000186	0.00185	CcSEcCtD
Ropivacaine—Cardiac disorder—Docetaxel—melanoma	0.000185	0.00184	CcSEcCtD
Ropivacaine—Constipation—Temozolomide—melanoma	0.000182	0.00181	CcSEcCtD
Ropivacaine—Pain—Temozolomide—melanoma	0.000182	0.00181	CcSEcCtD
Ropivacaine—Feeling abnormal—Carmustine—melanoma	0.000182	0.0018	CcSEcCtD
Ropivacaine—Asthenia—Bleomycin—melanoma	0.000181	0.0018	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Carmustine—melanoma	0.00018	0.00179	CcSEcCtD
Ropivacaine—Chills—Docetaxel—melanoma	0.000179	0.00178	CcSEcCtD
Ropivacaine—Pruritus—Bleomycin—melanoma	0.000179	0.00177	CcSEcCtD
Ropivacaine—Arrhythmia—Docetaxel—melanoma	0.000178	0.00177	CcSEcCtD
Ropivacaine—Feeling abnormal—Temozolomide—melanoma	0.000175	0.00174	CcSEcCtD
Ropivacaine—Mental disorder—Docetaxel—melanoma	0.000175	0.00173	CcSEcCtD
Ropivacaine—Body temperature increased—Carmustine—melanoma	0.000174	0.00173	CcSEcCtD
Ropivacaine—Abdominal pain—Carmustine—melanoma	0.000174	0.00173	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Temozolomide—melanoma	0.000174	0.00173	CcSEcCtD
Ropivacaine—Erythema—Docetaxel—melanoma	0.000174	0.00172	CcSEcCtD
Ropivacaine—Hypersensitivity—Dactinomycin—melanoma	0.000173	0.00172	CcSEcCtD
Ropivacaine—Urticaria—Temozolomide—melanoma	0.000169	0.00168	CcSEcCtD
Ropivacaine—Asthenia—Dactinomycin—melanoma	0.000169	0.00168	CcSEcCtD
Ropivacaine—Abdominal pain—Temozolomide—melanoma	0.000168	0.00167	CcSEcCtD
Ropivacaine—Body temperature increased—Temozolomide—melanoma	0.000168	0.00167	CcSEcCtD
Ropivacaine—Back pain—Docetaxel—melanoma	0.000168	0.00167	CcSEcCtD
Ropivacaine—Muscle spasms—Docetaxel—melanoma	0.000167	0.00166	CcSEcCtD
Ropivacaine—Hypersensitivity—Carmustine—melanoma	0.000162	0.00161	CcSEcCtD
Ropivacaine—Diarrhoea—Dactinomycin—melanoma	0.000161	0.0016	CcSEcCtD
Ropivacaine—Vomiting—Bleomycin—melanoma	0.000161	0.00159	CcSEcCtD
Ropivacaine—Anaemia—Docetaxel—melanoma	0.00016	0.00159	CcSEcCtD
Ropivacaine—Tocainide—ALB—melanoma	0.00016	0.0237	CrCbGaD
Ropivacaine—Rash—Bleomycin—melanoma	0.000159	0.00158	CcSEcCtD
Ropivacaine—Dermatitis—Bleomycin—melanoma	0.000159	0.00158	CcSEcCtD
Ropivacaine—Asthenia—Carmustine—melanoma	0.000158	0.00157	CcSEcCtD
Ropivacaine—Hypersensitivity—Temozolomide—melanoma	0.000157	0.00156	CcSEcCtD
Ropivacaine—Syncope—Docetaxel—melanoma	0.000156	0.00155	CcSEcCtD
Ropivacaine—Asthenia—Temozolomide—melanoma	0.000153	0.00152	CcSEcCtD
Ropivacaine—Loss of consciousness—Docetaxel—melanoma	0.000153	0.00152	CcSEcCtD
Ropivacaine—Cough—Docetaxel—melanoma	0.000151	0.0015	CcSEcCtD
Ropivacaine—Diarrhoea—Carmustine—melanoma	0.000151	0.0015	CcSEcCtD
Ropivacaine—Pruritus—Temozolomide—melanoma	0.000151	0.0015	CcSEcCtD
Ropivacaine—Convulsion—Docetaxel—melanoma	0.00015	0.00149	CcSEcCtD
Ropivacaine—Nausea—Bleomycin—melanoma	0.00015	0.00149	CcSEcCtD
Ropivacaine—Hypertension—Docetaxel—melanoma	0.00015	0.00149	CcSEcCtD
Ropivacaine—Vomiting—Dactinomycin—melanoma	0.00015	0.00149	CcSEcCtD
Ropivacaine—Rash—Dactinomycin—melanoma	0.000148	0.00147	CcSEcCtD
Ropivacaine—Myalgia—Docetaxel—melanoma	0.000148	0.00147	CcSEcCtD
Ropivacaine—Arthralgia—Docetaxel—melanoma	0.000148	0.00147	CcSEcCtD
Ropivacaine—Chest pain—Docetaxel—melanoma	0.000148	0.00147	CcSEcCtD
Ropivacaine—Dizziness—Carmustine—melanoma	0.000146	0.00145	CcSEcCtD
Ropivacaine—Diarrhoea—Temozolomide—melanoma	0.000146	0.00145	CcSEcCtD
Ropivacaine—Confusional state—Docetaxel—melanoma	0.000143	0.00142	CcSEcCtD
Ropivacaine—Anaphylactic shock—Docetaxel—melanoma	0.000142	0.00141	CcSEcCtD
Ropivacaine—Dizziness—Temozolomide—melanoma	0.000141	0.0014	CcSEcCtD
Ropivacaine—Infection—Docetaxel—melanoma	0.000141	0.0014	CcSEcCtD
Ropivacaine—Vomiting—Carmustine—melanoma	0.00014	0.00139	CcSEcCtD
Ropivacaine—Nausea—Dactinomycin—melanoma	0.00014	0.00139	CcSEcCtD
Ropivacaine—Shock—Docetaxel—melanoma	0.000139	0.00138	CcSEcCtD
Ropivacaine—Rash—Carmustine—melanoma	0.000139	0.00138	CcSEcCtD
Ropivacaine—Dermatitis—Carmustine—melanoma	0.000139	0.00138	CcSEcCtD
Ropivacaine—Thrombocytopenia—Docetaxel—melanoma	0.000139	0.00138	CcSEcCtD
Ropivacaine—Tachycardia—Docetaxel—melanoma	0.000138	0.00137	CcSEcCtD
Ropivacaine—Headache—Carmustine—melanoma	0.000138	0.00137	CcSEcCtD
Ropivacaine—Skin disorder—Docetaxel—melanoma	0.000138	0.00137	CcSEcCtD
Ropivacaine—Vomiting—Temozolomide—melanoma	0.000135	0.00135	CcSEcCtD
Ropivacaine—Rash—Temozolomide—melanoma	0.000134	0.00133	CcSEcCtD
Ropivacaine—Dermatitis—Temozolomide—melanoma	0.000134	0.00133	CcSEcCtD
Ropivacaine—Headache—Temozolomide—melanoma	0.000133	0.00133	CcSEcCtD
Ropivacaine—Hypotension—Docetaxel—melanoma	0.000132	0.00131	CcSEcCtD
Ropivacaine—Nausea—Carmustine—melanoma	0.000131	0.0013	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000129	0.00128	CcSEcCtD
Ropivacaine—Insomnia—Docetaxel—melanoma	0.000128	0.00127	CcSEcCtD
Ropivacaine—Paraesthesia—Docetaxel—melanoma	0.000127	0.00126	CcSEcCtD
Ropivacaine—Nausea—Temozolomide—melanoma	0.000126	0.00126	CcSEcCtD
Ropivacaine—Dyspnoea—Docetaxel—melanoma	0.000126	0.00125	CcSEcCtD
Ropivacaine—Somnolence—Docetaxel—melanoma	0.000126	0.00125	CcSEcCtD
Ropivacaine—Dyspepsia—Docetaxel—melanoma	0.000125	0.00124	CcSEcCtD
Ropivacaine—Pain—Docetaxel—melanoma	0.000121	0.0012	CcSEcCtD
Ropivacaine—Constipation—Docetaxel—melanoma	0.000121	0.0012	CcSEcCtD
Ropivacaine—Lidocaine—ABCB1—melanoma	0.000118	0.0175	CrCbGaD
Ropivacaine—Feeling abnormal—Docetaxel—melanoma	0.000117	0.00116	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Docetaxel—melanoma	0.000116	0.00115	CcSEcCtD
Ropivacaine—Abdominal pain—Docetaxel—melanoma	0.000112	0.00111	CcSEcCtD
Ropivacaine—Body temperature increased—Docetaxel—melanoma	0.000112	0.00111	CcSEcCtD
Ropivacaine—Hypersensitivity—Docetaxel—melanoma	0.000104	0.00104	CcSEcCtD
Ropivacaine—Asthenia—Docetaxel—melanoma	0.000102	0.00101	CcSEcCtD
Ropivacaine—Pruritus—Docetaxel—melanoma	0.0001	0.000995	CcSEcCtD
Ropivacaine—Diarrhoea—Docetaxel—melanoma	9.69e-05	0.000963	CcSEcCtD
Ropivacaine—Dizziness—Docetaxel—melanoma	9.36e-05	0.00093	CcSEcCtD
Ropivacaine—Vomiting—Docetaxel—melanoma	9e-05	0.000895	CcSEcCtD
Ropivacaine—Rash—Docetaxel—melanoma	8.93e-05	0.000887	CcSEcCtD
Ropivacaine—Dermatitis—Docetaxel—melanoma	8.92e-05	0.000886	CcSEcCtD
Ropivacaine—Headache—Docetaxel—melanoma	8.87e-05	0.000881	CcSEcCtD
Ropivacaine—Nausea—Docetaxel—melanoma	8.41e-05	0.000836	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—VEGFA—melanoma	2.37e-05	0.000195	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—VEGFA—melanoma	2.37e-05	0.000195	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—STAT3—melanoma	2.34e-05	0.000193	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—STAT3—melanoma	2.34e-05	0.000193	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—NRAS—melanoma	2.34e-05	0.000193	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—NRAS—melanoma	2.34e-05	0.000193	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MAPK3—melanoma	2.33e-05	0.000192	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MAPK1—melanoma	2.32e-05	0.000191	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—EGFR—melanoma	2.32e-05	0.000191	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—HRAS—melanoma	2.31e-05	0.00019	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—HRAS—melanoma	2.31e-05	0.00019	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—HRAS—melanoma	2.3e-05	0.000189	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—IL6—melanoma	2.29e-05	0.000189	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—IL6—melanoma	2.29e-05	0.000189	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—VEGFA—melanoma	2.28e-05	0.000188	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—VEGFA—melanoma	2.28e-05	0.000188	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—STAT3—melanoma	2.26e-05	0.000186	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—STAT3—melanoma	2.26e-05	0.000186	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—FGF2—melanoma	2.26e-05	0.000186	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—NRAS—melanoma	2.25e-05	0.000186	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—NRAS—melanoma	2.25e-05	0.000186	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—VEGFA—melanoma	2.25e-05	0.000185	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MAPK3—melanoma	2.24e-05	0.000184	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MAPK3—melanoma	2.24e-05	0.000184	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—NRAS—melanoma	2.22e-05	0.000183	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MAPK1—melanoma	2.22e-05	0.000183	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—EGFR—melanoma	2.22e-05	0.000183	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—IL6—melanoma	2.21e-05	0.000182	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—IL6—melanoma	2.21e-05	0.000182	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TNF—melanoma	2.21e-05	0.000182	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—IL6—melanoma	2.2e-05	0.000181	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—KRAS—melanoma	2.19e-05	0.00018	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ACER3—melanoma	2.18e-05	0.00018	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MAPK3—melanoma	2.16e-05	0.000178	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MAPK3—melanoma	2.16e-05	0.000178	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP1B1—melanoma	2.14e-05	0.000176	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MAPK1—melanoma	2.13e-05	0.000175	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MAPK1—melanoma	2.13e-05	0.000175	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—EGFR—melanoma	2.13e-05	0.000175	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—EGFR—melanoma	2.13e-05	0.000175	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MAPK3—melanoma	2.13e-05	0.000175	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TNF—melanoma	2.11e-05	0.000174	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	2.11e-05	0.000174	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	2.1e-05	0.000173	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—KRAS—melanoma	2.09e-05	0.000172	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—ERBB2—melanoma	2.08e-05	0.000172	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MAPK1—melanoma	2.05e-05	0.000169	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MAPK1—melanoma	2.05e-05	0.000169	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—EGFR—melanoma	2.05e-05	0.000169	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—EGFR—melanoma	2.05e-05	0.000169	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	2.04e-05	0.000168	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—AKT1—melanoma	2.03e-05	0.000167	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TNF—melanoma	2.03e-05	0.000167	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TNF—melanoma	2.03e-05	0.000167	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MAPK1—melanoma	2.02e-05	0.000167	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—EGFR—melanoma	2.02e-05	0.000167	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PLCB4—melanoma	2.02e-05	0.000167	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—KRAS—melanoma	2.01e-05	0.000166	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—KRAS—melanoma	2.01e-05	0.000166	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—UGT2B10—melanoma	1.99e-05	0.000164	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	1.96e-05	0.000162	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TNF—melanoma	1.96e-05	0.000161	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TNF—melanoma	1.96e-05	0.000161	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—KRAS—melanoma	1.94e-05	0.00016	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—KRAS—melanoma	1.94e-05	0.00016	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—KRAS—melanoma	1.91e-05	0.000157	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SLC6A11—melanoma	1.9e-05	0.000157	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIP4K2A—melanoma	1.9e-05	0.000157	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—HRAS—melanoma	1.86e-05	0.000153	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HS3ST5—melanoma	1.85e-05	0.000153	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MTAP—melanoma	1.85e-05	0.000152	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ACER3—melanoma	1.85e-05	0.000152	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CTNNB1—melanoma	1.82e-05	0.00015	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP9—melanoma	1.79e-05	0.000147	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—IL6—melanoma	1.78e-05	0.000147	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—HRAS—melanoma	1.78e-05	0.000147	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—NFKB1—melanoma	1.77e-05	0.000146	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—HRAS—melanoma	1.71e-05	0.000141	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—HRAS—melanoma	1.71e-05	0.000141	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—IL6—melanoma	1.7e-05	0.00014	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—UGT2B10—melanoma	1.69e-05	0.000139	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	1.67e-05	0.000137	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PHGDH—melanoma	1.65e-05	0.000136	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—LUM—melanoma	1.65e-05	0.000136	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—HRAS—melanoma	1.65e-05	0.000136	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—HRAS—melanoma	1.65e-05	0.000136	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—AKT1—melanoma	1.64e-05	0.000135	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—IL6—melanoma	1.64e-05	0.000135	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—IL6—melanoma	1.64e-05	0.000135	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—HRAS—melanoma	1.62e-05	0.000134	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HPSE—melanoma	1.62e-05	0.000133	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—VEGFA—melanoma	1.6e-05	0.000132	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—STAT3—melanoma	1.59e-05	0.000131	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CUBN—melanoma	1.59e-05	0.000131	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—NRAS—melanoma	1.58e-05	0.00013	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—IL6—melanoma	1.58e-05	0.00013	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—IL6—melanoma	1.58e-05	0.00013	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—AKT1—melanoma	1.57e-05	0.000129	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HS3ST5—melanoma	1.57e-05	0.000129	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—IL6—melanoma	1.55e-05	0.000128	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SDHD—melanoma	1.53e-05	0.000126	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—BSG—melanoma	1.53e-05	0.000126	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CSPG4—melanoma	1.53e-05	0.000126	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MAPK3—melanoma	1.52e-05	0.000125	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—AKT1—melanoma	1.51e-05	0.000124	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—AKT1—melanoma	1.51e-05	0.000124	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GPAM—melanoma	1.48e-05	0.000122	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—AKT1—melanoma	1.46e-05	0.00012	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—AKT1—melanoma	1.46e-05	0.00012	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MAPK1—melanoma	1.44e-05	0.000119	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—EGFR—melanoma	1.44e-05	0.000119	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ACER3—melanoma	1.43e-05	0.000117	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PLCB4—melanoma	1.41e-05	0.000116	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TNF—melanoma	1.37e-05	0.000113	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—KRAS—melanoma	1.36e-05	0.000112	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SLC6A11—melanoma	1.32e-05	0.000109	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIP4K2A—melanoma	1.32e-05	0.000109	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—UGT2B10—melanoma	1.3e-05	0.000107	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MTAP—melanoma	1.29e-05	0.000106	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.26e-05	0.000104	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PLA2G6—melanoma	1.26e-05	0.000104	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HS3ST5—melanoma	1.21e-05	9.99e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PLCB4—melanoma	1.19e-05	9.81e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	1.17e-05	9.63e-05	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—HRAS—melanoma	1.16e-05	9.55e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PHGDH—melanoma	1.15e-05	9.44e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LUM—melanoma	1.15e-05	9.44e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—VCAN—melanoma	1.13e-05	9.34e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HPSE—melanoma	1.12e-05	9.26e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIP4K2A—melanoma	1.12e-05	9.22e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SLC6A11—melanoma	1.12e-05	9.22e-05	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—IL6—melanoma	1.11e-05	9.14e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CUBN—melanoma	1.1e-05	9.09e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MTAP—melanoma	1.09e-05	8.97e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SDHD—melanoma	1.07e-05	8.77e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CSPG4—melanoma	1.07e-05	8.77e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—BSG—melanoma	1.07e-05	8.77e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.06e-05	8.77e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GPAM—melanoma	1.03e-05	8.5e-05	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—AKT1—melanoma	1.02e-05	8.43e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PHGDH—melanoma	9.71e-06	8e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LUM—melanoma	9.71e-06	8e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP17A1—melanoma	9.56e-06	7.88e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HPSE—melanoma	9.52e-06	7.84e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CUBN—melanoma	9.34e-06	7.7e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLCB4—melanoma	9.19e-06	7.57e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GNA11—melanoma	9.03e-06	7.44e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SDHD—melanoma	9.02e-06	7.43e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—BSG—melanoma	9.02e-06	7.43e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CSPG4—melanoma	9.02e-06	7.43e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—FASN—melanoma	8.84e-06	7.28e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PLA2G6—melanoma	8.77e-06	7.23e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GPAM—melanoma	8.74e-06	7.2e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SLC5A5—melanoma	8.69e-06	7.16e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SLC6A11—melanoma	8.64e-06	7.12e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIP4K2A—melanoma	8.64e-06	7.12e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MTAP—melanoma	8.4e-06	6.92e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GNAQ—melanoma	8.4e-06	6.92e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CD44—melanoma	8.4e-06	6.92e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP1B1—melanoma	8.05e-06	6.63e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—VCAN—melanoma	7.88e-06	6.49e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LUM—melanoma	7.49e-06	6.17e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PHGDH—melanoma	7.49e-06	6.17e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PLA2G6—melanoma	7.43e-06	6.12e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HPSE—melanoma	7.35e-06	6.05e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CUBN—melanoma	7.21e-06	5.94e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SDHD—melanoma	6.96e-06	5.74e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CSPG4—melanoma	6.96e-06	5.74e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—BSG—melanoma	6.96e-06	5.74e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GPAM—melanoma	6.74e-06	5.56e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—VCAN—melanoma	6.67e-06	5.5e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP17A1—melanoma	6.65e-06	5.48e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ABCB1—melanoma	6.63e-06	5.46e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.32e-06	5.2e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GNA11—melanoma	6.28e-06	5.17e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—FASN—melanoma	6.14e-06	5.06e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PRKCA—melanoma	6.1e-06	5.03e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.1e-06	5.02e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ERCC2—melanoma	6.05e-06	4.98e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SLC5A5—melanoma	6.04e-06	4.98e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GNAQ—melanoma	5.84e-06	4.81e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CD44—melanoma	5.84e-06	4.81e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLA2G6—melanoma	5.73e-06	4.72e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP17A1—melanoma	5.63e-06	4.64e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP1B1—melanoma	5.6e-06	4.61e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.55e-06	4.58e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	5.48e-06	4.52e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GNA11—melanoma	5.32e-06	4.38e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—FASN—melanoma	5.2e-06	4.29e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—VCAN—melanoma	5.15e-06	4.24e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SLC5A5—melanoma	5.12e-06	4.22e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GNAQ—melanoma	4.94e-06	4.07e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CD44—melanoma	4.94e-06	4.07e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.84e-06	3.99e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.8e-06	3.95e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CG—melanoma	4.78e-06	3.94e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP1B1—melanoma	4.74e-06	3.9e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPARG—melanoma	4.61e-06	3.8e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ABCB1—melanoma	4.61e-06	3.8e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP17A1—melanoma	4.35e-06	3.58e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PRKCA—melanoma	4.24e-06	3.49e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ERCC2—melanoma	4.21e-06	3.46e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CD—melanoma	4.2e-06	3.46e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.18e-06	3.45e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALB—melanoma	4.15e-06	3.42e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GNA11—melanoma	4.1e-06	3.38e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—FASN—melanoma	4.02e-06	3.31e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SLC5A5—melanoma	3.95e-06	3.25e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ABCB1—melanoma	3.9e-06	3.22e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CD44—melanoma	3.82e-06	3.14e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GNAQ—melanoma	3.82e-06	3.14e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CB—melanoma	3.66e-06	3.02e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP1B1—melanoma	3.66e-06	3.01e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTGS2—melanoma	3.63e-06	2.99e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PRKCA—melanoma	3.59e-06	2.96e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ERCC2—melanoma	3.56e-06	2.94e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CG—melanoma	3.32e-06	2.74e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPARG—melanoma	3.21e-06	2.64e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTEN—melanoma	3.16e-06	2.61e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ABCB1—melanoma	3.01e-06	2.48e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.95e-06	2.43e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CD—melanoma	2.92e-06	2.41e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALB—melanoma	2.88e-06	2.37e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CG—melanoma	2.81e-06	2.32e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PRKCA—melanoma	2.77e-06	2.28e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ERCC2—melanoma	2.75e-06	2.27e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPARG—melanoma	2.72e-06	2.24e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CB—melanoma	2.55e-06	2.1e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTGS2—melanoma	2.52e-06	2.08e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CD—melanoma	2.47e-06	2.04e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALB—melanoma	2.44e-06	2.01e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CA—melanoma	2.23e-06	1.84e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTEN—melanoma	2.2e-06	1.81e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CG—melanoma	2.17e-06	1.79e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CB—melanoma	2.16e-06	1.78e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTGS2—melanoma	2.14e-06	1.76e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPARG—melanoma	2.1e-06	1.73e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CD—melanoma	1.91e-06	1.57e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALB—melanoma	1.88e-06	1.55e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTEN—melanoma	1.86e-06	1.53e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKT1—melanoma	1.82e-06	1.5e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CB—melanoma	1.66e-06	1.37e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTGS2—melanoma	1.65e-06	1.36e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CA—melanoma	1.55e-06	1.28e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTEN—melanoma	1.44e-06	1.18e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CA—melanoma	1.31e-06	1.08e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKT1—melanoma	1.27e-06	1.04e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKT1—melanoma	1.07e-06	8.85e-06	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CA—melanoma	1.01e-06	8.36e-06	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKT1—melanoma	8.29e-07	6.83e-06	CbGpPWpGaD
